Immunocore Holdings (IMCR) Research & Development: 2021-2025
Historic Research & Development for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to $70.6 million.
- Immunocore Holdings' Research & Development rose 33.74% to $70.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $256.9 million, marking a year-over-year increase of 24.19%. This contributed to the annual value of $222.2 million for FY2024, which is 35.83% up from last year.
- Immunocore Holdings' Research & Development amounted to $70.6 million in Q3 2025, which was up 2.27% from $69.0 million recorded in Q2 2025.
- Immunocore Holdings' 5-year Research & Development high stood at $70.6 million for Q3 2025, and its period low was -$27.1 million during Q4 2021.
- In the last 3 years, Immunocore Holdings' Research & Development had a median value of $52.8 million in 2024 and averaged $52.9 million.
- Its Research & Development has fluctuated over the past 5 years, first spiked by 57.11% in 2024, then decreased by 1.72% in 2025.
- Over the past 4 years, Immunocore Holdings' Research & Development (Quarterly) stood at -$27.1 million in 2021, then reached $45.6 million in 2023, then soared by 33.55% to $60.9 million in 2024, then skyrocketed by 33.74% to $70.6 million in 2025.
- Its last three reported values are $70.6 million in Q3 2025, $69.0 million for Q2 2025, and $56.5 million during Q1 2025.